Samsca.
- Published in:
- Formulary, 2009, v. 44, n. 7, p. 194
- Publication type:
- Article
Works matching DE "OTSUKA Pharmaceutical Co. Ltd."
Results: 22
1
2
Product News.
- Published in:
- 2005
- Publication type:
- Product Review
3
Majority of doctors do not have good understanding about Fluid & Electrolytes-Dr. Asif Qureshi.
- Published in:
- Pulse International, 2017, v. 18, n. 3, p. 22
- Publication type:
- Article
4
Otsuka Awareness Campaign against Hepatitis - We should know the intensity of the problem to tackle it.
- Published in:
- Pulse International, 2016, v. 17, n. 11, p. 42
- Publication type:
- Article
5
Otsuka awareness campaign against Hepatitis.
- Published in:
- Pulse International, 2014, v. 15, n. 5, p. 11
- Publication type:
- Article
6
700,000 patients examined at Otsuka Welfare Clinic in 10 Years.
- Published in:
- Pulse International, 2013, v. 14, n. 24, p. 3
- Publication type:
- Article
7
Sepsis is another major killer disease which requires immediate attention.
- Published in:
- Pulse International, 2012, v. 13, n. 24, p. 1
- By:
- Publication type:
- Article
8
Otsuka awareness campaign against hepatitis.
- Published in:
- Pulse International, 2012, v. 13, n. 13, p. 10
- Publication type:
- Article
9
Otsuka's Delamanid shows promising results in treatment of MDR-TB.
- Published in:
- Pulse International, 2012, v. 13, n. 12, p. 11
- Publication type:
- Article
10
Dr. Khemchand. N. Moorani performs Otsuka lucky draw.
- Published in:
- Pulse International, 2012, v. 13, n. 7, p. 14
- Publication type:
- Article
11
Abilify approved by the US FDA for add-on treatment of major depressive disorder.
- Published in:
- Expert Review of Neurotherapeutics, 2008, v. 8, n. 1, p. 7
- Publication type:
- Article
12
Access sought to tuberculosis drug from nutraceutical company.
- Published in:
- Nature Medicine, 2015, v. 21, n. 2, p. 103, doi. 10.1038/nm.3805
- By:
- Publication type:
- Article
13
Abilify Injection Launched.
- Published in:
- Journal of Psychosocial Nursing & Mental Health Services, 2007, v. 45, n. 2, p. 41
- Publication type:
- Article
14
Trial watch: Novel antimicrobial fights TB resistance.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 8, p. 590, doi. 10.1038/nrd3809
- By:
- Publication type:
- Article
15
Antipsychotic approved for teens.
- Published in:
- Contemporary Pediatrics, 2007, v. 24, n. 12, p. 15
- Publication type:
- Article
16
Aripiprazole approved for bipolar mania.
- Published in:
- Brown University Psychopharmacology Update, 2004, v. 15, n. 11, p. 8
- Publication type:
- Article
17
Singular Approaches to Combination Trials.
- Published in:
- Applied Clinical Trials, 2014, v. 23, n. 4/5, p. 12
- By:
- Publication type:
- Article
18
Otsuka snaps up cancer drugmaker Astex.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 11, p. 946, doi. 10.1038/nbt1113-946
- By:
- Publication type:
- Article
19
LITIGATING AVIATION CASES.
- Published in:
- Brief, 2016, v. 45, n. 3, p. 41
- By:
- Publication type:
- Article
20
Drug therapy smartens up.
- Published in:
- Nature Nanotechnology, 2015, v. 10, n. 11, p. 910, doi. 10.1038/nnano.2015.267
- By:
- Publication type:
- Article
21
The Supply Chain Gang: Enforcing the Employment Rights of Subcontracted Labour in Ontario.
- Published in:
- Canadian Labour & Employment Law Journal, 2012, v. 16, n. 1, p. 449
- By:
- Publication type:
- Article
22
Plelal now approved.
- Published in:
- 2009
- Publication type:
- Product Review